Red Blood Cell Transfusion Rate Highest With Persistent ESA Hyporesponse
Red blood cell transfusion to treat anemia of dialysis is more common with persistent hyporesponse to erythropoiesis-stimulating agents (ESA).
Stay updated with breaking news from Milliman Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Red blood cell transfusion to treat anemia of dialysis is more common with persistent hyporesponse to erythropoiesis-stimulating agents (ESA).
Hyporesponse to erythropoiesis-stimulating agents was associated with increased rates of red blood cell transfusions and poorer outcomes in patients with chronic kidney disease, highlighting the need for alternative anemia treatments.
Obama's proposed PPACA will further increase state budget deficits. Find out how here.
On January 30, 2023, New York Governor Kathy Hochul vetoed Senate Bill S74A, also known as the “Grieving Families Act.” The Act sought to expand the compensable damages in wrongful...
Intense efforts by the Legislature to modernize New York’s wrongful death laws came to a screeching halt last night. Just before the deadline, Governor Kathy Hochul vetoed the...